Terms ending in 2039
Every in-force patent on Shire LLC's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,260,064 | Stable Corticosteroid Compositions In force · High confidence | Viropharma Biologics LLC | In force | High confidence | |
| US 11,564,934 | Stable Corticosteroid Compositions In force · Medium confidence | Viropharma Biologics LLC | In force | Medium confidence | |
| US D1,012,092 | Display Screen with a Transitional Graphical User Interface In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 12,241,814 | Syringe Screening Device In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 10,487,571 | Pass Through Access Opening Closure Device In force · High confidence | Shire Valley Design, LLC | In force | High confidence | |
| US 11,685,912 | Affinity Purification of Glycoside-Cleaving Enzymes In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 10,730,874 | Inhibitors of Plasma Kallikrein and Uses Thereof In force · High confidence | Takeda Pharmaceutical Company Limited | In force | High confidence | |
| US 11,352,356 | Inhibitors of Plasma Kallikrein and Uses Thereof In force · High confidence | Shire Human Genetic Therapies, Inc. | In force | High confidence | |
| US 12,065,448 | Heteroaryl Plasma Kallikrein Inhibitors In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| US 12,441,724 | Inhibitors of Plasma Kallikrein and Uses Thereof In force · Medium confidence | Takeda Pharmaceutical Company Limited | In force | Medium confidence | |
| 5 more term ends in 2039 · Pro | |||||
10 of 15 patents shown. Soonest term end first, then patent number.
Pro members see all 15.
3 of these are in force and held by Shire LLC.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.